Atlas Trials

Research Study to Look at How Well Cagrilintide Together With Semaglutide Works in People With Type 2 Diabetes

Clinical trial NCT04982575 · COMPLETED

Trial details

NCT number
NCT04982575
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus, Type 2
Start date
2021-08-02
Primary completion
2022-07-07
Enrollment
92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.